Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04121325 · ClinicalTrials.gov registry record
Gastric Electrical Stimulation for Abdominal Pain in Gastroparesis
A clinical trial, sponsored by University of Louisville.
- Terminated
- Registry status
- 4
- Enrollment target
NCT04121325: Clinical Trial study, sponsored by University of Louisville.
NCT04121325 is a clinical trial that was terminated before completion, run by University of Louisville. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04121325 was terminated before completion, sponsored by University of Louisville.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
To conduct a pilot study to evaluate the effects of new GES programming settings on abdominal pain in patients with gastroparesis and existing GES devices, whose abdominal pain has so far been refractory to drugs and/or devices.
Primary Outcome
Abdominal Pain by Brief Pain Inventory. The values are 0-10, with 10 being worse outcome.
Interventions
- DEVICE Enterra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-12-18 |
| Est. Completion | 2020-03-13 |
Why NCT04121325 stopped before completion
NCT04121325 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Enterra is the first listed.
NCT04121325 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04121325 about?
NCT04121325 is a clinical study titled "Gastric Electrical Stimulation for Abdominal Pain in Gastroparesis". To conduct a pilot study to evaluate the effects of new GES programming settings on abdominal pain in patients with gastroparesis and existing GES devices, whose abdominal pain has so far been refractory to drugs and/or devices.
What is the current status of trial NCT04121325?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2019-12-18. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT04121325?
The interventions under investigation include: Enterra (DEVICE).
Who is sponsoring clinical trial NCT04121325?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI